6/21/2024

Nystatin Oral Suspension

Products Affected - Description

- Nystatin oral suspension, Leading, 100,000 unit/mL, 473 mL bottle, NDC 69315-0504-47
- Nystatin oral suspension, Leading, 100,000 unit/mL, 60 mL bottle, NDC 69315-0504-60
- Nystatin oral suspension, Pharmaceutical Associates, Inc., 100,000 unit/mL, 473 mL bottle, NDC 00121-0868-16
- Nystatin oral suspension, Pharmaceutical Associates, Inc., 100,000 unit/mL, 60 mL bottle, NDC 00121-0868-02
- Nystatin oral suspension, Wockhardt USA, 100,000 units/mL, 473 mL bottle, NDC 60432-0537-16 - discontinued
- Nystatin oral suspension, Wockhardt USA, 100,000 units/mL, 60 mL bottle, NDC 60432-0537-60 - discontinued

Reason for the Shortage

- Leading Pharma did not provide a reason for the shortage.
- Pharmaceutical Associates did not provide a reason for the shortage.
- Wockhardt discontinued nystatin suspension and the company is distributing remaining inventory (short-dated).

Available Products

- There is insufficient supply for usual ordering

Estimated Resupply Dates

- Leading Pharma has nystatin 100,000 unit/mL suspension in 60 mL and 473 mL bottles on allocation.
- Pharmaceutical Associates has nystatin 100,000 unit/mL suspension in 60 mL and 473 mL bottles on back order and the company cannot estimate a release date.

Updated

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.